By Bryan A. Wolf, MD, PhD, Chief Scientific Officer and Director of the Research Institute
As the summer comes to a close and children prepare to head back to school, it is an opportunity for us all to sit up straight and study up on the value of the work that we do as pediatric researchers to help children thrive.
A new issue of Bench to Bedside, the monthly newsmagazine from The Children’s Hospital of Philadelphia Research Institute, is now available! This month’s issue includes several stories that show that, sometimes, it takes some setbacks to pave a new and unexpected path to success in research.
A blizzard of research happenings and news — from initiatives that are pushing precision medicine forward to a new way of thinking about how cancer progresses — appear in the January issue of Bench to Bedside.
Despite advances in T-cell acute lymphoblastic leukemia treatment, between 15 and 20 percent of children who achieve an initial complete remission will relapse. They may need more intensive therapy or alternative approaches, but physicians do not yet have a reliable way of predicting which patients are at high-risk of relapse.
